Biogen (BIIB) Invested Capital (2009 - 2026)

Biogen's Invested Capital history runs 18 years deep, the most recent figure standing at $24.9 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 15.85% year-over-year to $24.9 billion; the TTM figure through Mar 2026 stood at $24.9 billion (up 15.85% YoY), while the FY2025 annual figure was $24.5 billion, up 15.43% from the prior year.
• Invested Capital was $24.9 billion for Q1 2026 at Biogen, up from $24.5 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $24.9 billion in Q1 2026 to a low of $6.3 billion in Q3 2025.
• Historically, Invested Capital has averaged $20.3 billion across 5 years, with a median of $21.3 billion in 2024.
• The sharpest annual moves came in 2025 and 2026: Invested Capital tumbled 69.69% in 2025, then climbed 15.85% in 2026.
• A 5-year view of Invested Capital shows it stood at $19.7 billion in 2022, then advanced by 9.75% to $21.6 billion in 2023, then decreased by 1.5% to $21.3 billion in 2024, then rose by 15.43% to $24.5 billion in 2025, then gained by 1.62% to $24.9 billion in 2026.
• The last three Invested Capital figures came in at $24.9 billion (Q1 2026), $24.5 billion (Q4 2025), and $6.3 billion (Q3 2025), per Business Quant data.